Exelixis Net Income vs. EBITDA
| EXEL Stock | USD 35.61 0.78 2.24% |
Net Income | First Reported 1999-12-31 | Previous Quarter 226.1 M | Current Value 118 M | Quarterly Volatility 65.2 M |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 1.14 | 0.9632 |
|
|
For Exelixis profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Exelixis to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Exelixis utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Exelixis's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Exelixis over time as well as its relative position and ranking within its peers.
Exelixis |
Exelixis' Revenue Breakdown by Earning Segment
Check out Investing Opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Exelixis. If investors know Exelixis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Exelixis listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 121.699 | Earnings Share 1.55 | Revenue Per Share 7.032 | Quarterly Revenue Growth 0.143 | Return On Assets 0.1281 |
The market value of Exelixis is measured differently than its book value, which is the value of Exelixis that is recorded on the company's balance sheet. Investors also form their own opinion of Exelixis' value that differs from its market value or its book value, called intrinsic value, which is Exelixis' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Exelixis' market value can be influenced by many factors that don't directly affect Exelixis' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Exelixis' value and its price as these two are different measures arrived at by different means. Investors typically determine if Exelixis is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Exelixis' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Exelixis EBITDA vs. Net Income Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Exelixis's current stock value. Our valuation model uses many indicators to compare Exelixis value to that of its competitors to determine the firm's financial worth. Exelixis is one of the top stocks in net income category among its peers. It also is one of the top stocks in ebitda category among its peers totaling about 0.95 of EBITDA per Net Income. The ratio of Net Income to EBITDA for Exelixis is roughly 1.06 . At this time, Exelixis' Net Income is quite stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Exelixis by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Exelixis EBITDA vs. Net Income
Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Exelixis |
| = | 207.76 M |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Exelixis |
| = | 196.6 M |
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Exelixis EBITDA Comparison
Exelixis is currently under evaluation in ebitda category among its peers.
Exelixis Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Exelixis, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Exelixis will eventually generate negative long term returns. The profitability progress is the general direction of Exelixis' change in net profit over the period of time. It can combine multiple indicators of Exelixis, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | -3.8 M | -3.9 M | |
| Operating Income | 170.9 M | 179.4 M | |
| Income Before Tax | 257.5 M | 270.4 M | |
| Total Other Income Expense Net | 86.6 M | 91 M | |
| Net Income | 207.8 M | 218.2 M | |
| Income Tax Expense | 49.8 M | 52.2 M | |
| Net Income From Continuing Ops | 92.1 M | 81 M | |
| Non Operating Income Net Other | -226.6 K | -237.9 K | |
| Net Income Applicable To Common Shares | 209.6 M | 220.1 M | |
| Net Interest Income | 82.1 M | 86.3 M | |
| Interest Income | 82.1 M | 86.3 M | |
| Change To Netincome | 177 M | 185.9 M | |
| Net Income Per Share | 0.73 | 0.77 | |
| Income Quality | 1.73 | 1.82 | |
| Net Income Per E B T | 0.79 | 1.06 |
Exelixis Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Exelixis. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Exelixis position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Exelixis' important profitability drivers and their relationship over time.
Use Exelixis in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Exelixis position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Exelixis will appreciate offsetting losses from the drop in the long position's value.Exelixis Pair Trading
Exelixis Pair Trading Analysis
The ability to find closely correlated positions to Exelixis could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Exelixis when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Exelixis - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Exelixis to buy it.
The correlation of Exelixis is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Exelixis moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Exelixis moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Exelixis can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Exelixis position
In addition to having Exelixis in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Target Risk ETFs Thematic Idea Now
Target Risk ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Target Risk ETFs theme has 32 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Target Risk ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Investing Opportunities. For more information on how to buy Exelixis Stock please use our How to buy in Exelixis Stock guide.You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
To fully project Exelixis' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Exelixis at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Exelixis' income statement, its balance sheet, and the statement of cash flows.